Liposomal Bupivacaine for Pain After Lumbar Fusion | MicrobiomeTrials← Back to trialsNCT07171125
Liposomal Bupivacaine for Pain After Lumbar Fusion
CompletedPHASE4INTERVENTIONAL
Trial Details
Start: 2025-09-20Est. Completion: 2026-02-28
Enrollment target: 204 participants Locations- Peking University Third Hospital, Beijing, China
Other microbiome trials you might be interested in
Spine DegenerationHip ArthritisKnee OsteoarthritisHip Fractures
This study aims to evaluate the effectiveness of a mobile application in improving postoperative rehabilitation outcomes…
New Haven, United StatesEst. completion Jul 2026
Delirium in Old Age
The project "QV-POD-2" is a prolongation based on "QV-POD-1", which was a quality contract program of the IQTIG - Instit…
Berlin, GermanyEst. completion Jun 2028
Recruiting
Acute Postoperative PainThoracic Surgical Procedures
This randomized, double-blind, sham-controlled study aims to evaluate the effects of transcutaneous electrical nerve sti…
Kaohsiung City, TaiwanEst. completion Oct 2026